Table 2.

Reasons for treatment discontinuation (FAS)

Reason for treatment discontinuationEverolimus 70 mg/wk (n = 99)Everolimus 10 mg/d (n = 100)
Discontinued, n (%)99 (100.0)100 (100.0)
 Disease progression79 (79.8)76 (76.0)
 Adverse event(s)7 (7.1)15 (15.0)
 Abnormal laboratory value(s)02 (2.0)
 Subject's condition no longer required study drug01 (1.0)
 Protocol violation1 (1.0)0
 Subject withdrew consent10 (10.1)3 (3.0)
 Lost to follow-up01 (1.0)
 Death2 (2.0)2 (2.0)